MedTech Adds 12 Industry Leaders to Board of Directors

Monday, November 10, 2014

MedTech Association, a membership-based trade association for the bioscience and medical technology (Bio/Med) industry in New York State, has added twelve highly-qualified community and industry leaders to its 2014-2015 board of directors. MedTech appreciates the distinguished efforts of its 2013-2014 board and looks forward to advancing the organization's mission with its new directors. For a complete listing of MedTech directors, visit http://www.medtech.org/about/board-of-directors.

Two Syracuse-area executives were named to the board:

Jeffrey Trubia
Partner, Testone, Marshall & Discenza, LLP

As a partner in the Tax Practice Group at Testone, Marshall & Discenza, LLP (TMD), Mr. Trubia provides expertise in accounting, tax consulting and business management to a diverse for-profit client base. With more than 16 years of experience, he specializes in working with the following industries: healthcare, manufacturing, real estate development and equipment, as well as construction. Trubia is able to maximize a client’s potential by offering analyses of overall profitability and developing a customized strategic action plan for their future. He is known for his strong personal skills and the energy he brings to helping TMD’s clients succeed. Trubia received his education at Le Moyne College.

Sarah Oliker
Assistant General Counsel, ConMed Corporation

Ms. Oliker is currently the assistant general counsel at ConMed Corporation. In this role, she advises on international and domestic distribution matters, health care provider arrangements, and provides strategic counsel on day-to-day matters affecting ConMed’s business. Oliker has over 15 years of healthcare experience. Prior to ConMed, Oliker served as senior counsel for ProCure Treatment Centers, Inc., where she structured complex physician arrangements and hospital joint ventures, provided health care regulatory and reimbursement counsel, as well as overseeing the Corporate Compliance Program.  Prior to ProCure, Oliker spent five years with Epstein Becker & Green in its Health Care & Life Sciences Group based in Washington, D.C., where her practice consisted of health regulatory and transactional matters, representing clients from all verticals of the health care industry. She is currently admitted to practice in Washington, D.C. and New York and is a member of the American Health Lawyers Association. She also serves as president of the Syracuse University Law Alumni Association. Oliker holds a bachelor’s from Colgate University and earned her JD at Syracuse University College of Law.   

Three Albany-area executives were named to the board:

Mark Frost
Executive Vice President & CFO, AngioDynamics, Inc.

Mr. Frost is the executive vice president and chief financial officer of AngioDyanmics, Inc. He joined the company in November 2012, bringing more than 25 years of global financial, administrative and operational experience, and a strong background in the healthcare industry. Prior to AngioDynamics, Frost most recently served as chief financial officer and senior vice president of administration of Albany Molecular Research Inc (AMRI). He earned a bachelor’s in International Relations/Economics, graduating cum laude with honors in Economics, from Colgate University, as well as completing INSEAD's global executive program.

Glenn Monastersky
Director of Operations and Associate Center Director, The Center for Biotechnology & Interdisciplinary Studies, Rensselaer Polytechnic Institute

Mr. Monastersky, Ph.D., is the director of operations and associate center director for the Center for Biotechnology & Interdisciplinary Studies at Rensselaer Polytechnic Institute (RPI). Monastersky has held various leadership positions in both clinical and corporate settings, most recently as the director of molecular medicine at the Rutgers Medical School. He holds a doctorate in Cell Biology from Rutgers University and conducted his post doc at Harvard Medical School and Genzyme Corporation.

Michael Williams
Senior Director and Assistant General Counsel, Regeneron Pharmaceuticals
Mr. Williams is a senior director and assistant general counsel for Regeneron Pharmaceuticals. In this role, he has legal responsibility for the Industrial Operations and Product Supply Group. Prior to Regeneron, Williams was the first in-house attorney for AMRI, a publicly-traded contract research/manufacturing company. With over 25 years of experience in both the business and legal fields, his specialties include intellectual property law and serving clients in the medical technology, biopharmaceuticals and venture capital verticals. Williams graduated from Lehigh University with a bachelor’s in Biochemistry and from Syracuse University College of Law. He is also a veteran, having served in the US Air Force from 1979-1983.

Four Rochester-area executives were named to the board:

Dan Carlson
Senior Director, Rochester Site Operations, Ortho Clinical Diagnostics

Mr. Carlson is the senior director of Rochester Site Operations for Ortho Clinical Diagnostics (OCD). He joined the company in April of 2014, bringing more than 30 years of operations and business experience to OCD. He was most recently a senior executive with the Eastman Kodak Company, serving as the general manager for the Retail Systems Solutions (RSS) Picture Kiosk business. Carlson graduated from Michigan Technological University with a bachelor’s in Electrical Engineering.

Greg Gdowski    
Executive Director, Center of Medical Technology and Innovation (CMTI), University of Rochester

Mr. Gdowski, Ph.D., is the executive director of the Center of Medical Technology and Innovation (CMTI) at the University of Rochester. With a background both in the academic research and industry/incubation settings, he was most recently a senior research engineering fellow at Blue Highway, where he managed ideation, invention, incubation and subsequent innovation opportunities. He also served on the faculty in Biomedical Engineering at the University of Rochester from 2001-2010 where he established and managed a NIH-funded research laboratory in vestibular sensory processing. Gdowski received his bachelor’s, master’s, and doctorate in Biomedical Engineering at Boston University, and his post-doctorate in Neuroscience at the University of Chicago.

Phil McLellan
Vice President, Global Operations, Laboratory Consumables Division, Thermo Fisher Scientific

Mr. McLellan is the vice president of global operations for the Laboratory Consumables Division of Thermo Fisher Scientific. In this role, he overseas manufacturing and distribution of all products for the division, focused on products serving customer applications including liquid handling, cell culture, bio production, drug discovery and diagnostics. With more than 25 years of manufacturing experience, including 13 years working in Toyota Motor Manufacturing, McLellan brings a strong sense for building a culture bent on the lean manufacturing of high quality products. McLellan received his bachelor’s from the Georgia institute of Technology in Medical Engineering.

Larry Ray
Chief Scientist, Carestream Health

Mr. Ray, Ph.D., has been with Carestream as chief scientist since 2007. Prior to this, he served as principal senior research scientist at Eastman Kodak Company. He has a doctorate and master’s in Mathematics from the University of Rochester and a bachelor’s in Mathematics from Union College. Ray currently holds dozens of patents.

One Buffalo-area executive was named to the board:

Patrick Whalen
Chief Operating Officer, Buffalo Niagara Medical Campus, Inc.
Mr. Whalen joined the Buffalo Niagara Medical Campus, Inc. (BNMC) as chief operating officer in March of 2008. In addition to managing the BNMC day-to-day operations, he is the BNMC’s unofficial “entrepreneur–in-residence.” As such, he works to foster collaboration and job creation on campus and throughout the bi-national region. A serial entrepreneur, Whalen has started over 20 businesses including Fulfillment Systems International (FSI), a logistics services provider offering marketing support, warehousing, distribution, freight forwarding and transportation service to firms operating in the US, Canada, and Europe. FSI grew from a start up to a firm with annual sales of $20 million and over one hundred employees in five locations in North America and Europe before being sold to a fortune-50 company: UPS in 2000. It is now part of UPS Supply Chain Services. Whalen is a graduate of the State University of New York at Buffalo’s School of Management Center for Entrepreneurial Leadership and attended Canisius College as well.


One New York City-area executive was named to the board:

Bethany Hills
Member, Epstein Becker GreenMs. Hills is a member of the firm in the Health Care and Life Sciences Practice in the New York office of Epstein Becker Green. She counsels life science, medical device and health care provider businesses on a broad range of reimbursement regulatory and compliance matters. Chambers USA has ranked Hills among the "Up-and-Coming Individuals" in the healthcare category in 2012 and 2013. She was named a "Rising Star" by New York Super Lawyers – Metro Edition in 2013. Additionally, Hills is a recipient of the ABA and BNA Award for Superior Academic Performance in the field of health law and earned a Lester Milbrath Fellowship from the Environment and Society Institute. Hills received her bachelor’s from the State University of New York College at Geneseo, her MPH at the State University at Buffalo’s School of Medicine and Biomedical Sciences and her JD at the State University of New York at Buffalo.

One Boston-area executive was named to the board:


Jeff Champagne
Director of Business Development, MPR Associates

Mr. Champagne is the director of business development at MPR Associates. Specializing in emerging technologies and research and development, he is able to help clients gain perspective, define company and product road maps, navigate obstacles and realize objectives to speed up commercialization efforts. As a trusted management consultant, his clients include top executives at the most innovative companies, the most prolific research institutions in the world and many Fortune 500 companies. Champagne has a background in marketing and business development, with a master’s from the University of Hartford.

View All News »